Table 2.

Associations of beclin-1 and LC3 expressions with chinicopathologic characteristics in ESCCs.

Factors	No	Beclin-1		p	LC3		p
		n (+)	n(-)		n(+)	n(-)
Age
≤65	83	50	33	0.381	37	46	0.216
>65	35	18	17		20	15
Sex
Male	98	54	44	0.223	49	49	0.419
Female	20	14	6		8	12
Tumor location
Upper	17	11	6	0.520	8	9	0.434
Middle	68	39	29		36	32
Lower	33	18	15		13	20
Surgical type
2-FL	60	37	23	0.371	31	29	0.462
3-FL	58	31	27		16	32
Differentiation
Well	8	4	4	0.226	7	1	0.750
Moderately	73	47	26		28	45
Poorly	37	17	20		22	15
T stage
T1+ T2	60	39	21	0.101	37	23	0.003
T3+T4	58	29	29		20	38
TNM stage
I	22	17	5	0.006	17	5	0.000
II	48	30	18		28	20
III	37	15	22		8	29
IV	11	6	5		4	7
Comorbidities
Highblood	60	27	33	0.004	28	32	0.720
Copd	13	9	4	0.374	8	5	0.316
Cardiovascular disease	19	11	8	0.980	12	7	0.160
Arrhythmia	11	6	5	0.830	4	7	0.410
Diabetes	40	23	17	0.984	17	23	0.370
Complications
90-day mortality	4	1	3	0.017	2	2	0.946
Fistula	13	4	9	0.038	5	8	0.456
Sepsis	11	4	7	0.136	6	5	0.667
Pneumonia	56	32	24	0.920	30	26	0.281
cardiac insufficiency	21	12	9	0.961	9	12	0.585
mTOR
Positive	62	28	34	0.005	25	37	0.097
Negative	56	40	16		32	24
LC3
Positive	57	35	22	0.427
Negative	61	33	28